Dental Bone Graft Substitutes Market Forecasts to 2030 - Global Analysis By Product, Material, Form, Application, End User and By Geography

According to Stratistics MRC, the Global Dental Bone Graft Substitutes Market is accounted for $1.35 billion in 2024 and is expected to reach $2.17 billion by 2030 growing at a CAGR of 9.7% during the forecast period. Dental bone graft substitutes are biomaterials used to promote bone regeneration and healing in areas where bone is insufficient, damaged, or resorbed. These substitutes serve as a scaffold for new bone growth, aiding in dental implant placement, periodontal repairs, and jaw reconstruction. They offers compatibility, ease of use, and structural support, making them essential in modern dental and maxillofacial procedures for restoring bone volume and density.

According to the article published by Dental Tribune International in June 2021, a large volume of patients demanded an implant procedure, which is a promising indicator for the growth of bone grafting.

Market Dynamics:

Driver:

Rising awareness of oral health

As people become more informed about the importance of maintaining healthy teeth and gums, there is an increased focus on preventive care, including dental implants, periodontal surgeries, and bone grafting procedures. This awareness leads to higher demand for dental bone graft substitutes, as they are essential for restoring bone volume and supporting implants. Additionally, greater knowledge of advanced treatment options drives patients to choose more effective, long-term solutions, thereby fueling market growth.

Restraint:

Risk of complications

The risk of complications in dental bone graft substitutes, such as infections, graft rejection, or insufficient bone integration, can deter patients from opting for the procedure. These complications may lead to delayed healing, the need for additional surgeries, or poor treatment outcomes. As a result, patients may hesitate to undergo grafting procedures, negatively impacting demand for substitutes. The fear of adverse effects and post-surgical challenges, especially among risk-prone individuals, hampers the market growth.

Opportunity:

Improved healthcare infrastructure

With better-equipped dental clinics, specialized facilities, and trained professionals, patients can receive more effective and timely treatments. This fosters the adoption of advanced dental procedures, including dental implants and bone grafting. Additionally, enhanced infrastructure promotes research and development of innovative grafting materials, improving treatment outcomes. As healthcare systems modernize, there is greater awareness of oral health, leading to increased demand for bone graft substitutes, further driving market expansion.

Threat:

High treatment costs

High treatment costs in dental bone graft substitutes arise due to the advanced materials used (such as synthetic, allografts, and xenografts), complex procedures, and the need for skilled professionals. These costs can include the price of the graft material, surgical procedures, and post-operative care. This financial burden limits accessibility, particularly in developing regions or for uninsured patients. As a result, many individuals may delay or avoid treatment, hindering market growth.

Covid-19 Impact

The covid-19 pandemic significantly impacted the dental bone graft substitutes market by disrupting supply chains, delaying elective dental procedures, and limiting patient access to dental care. With lockdowns and health concerns, demand for dental treatments, including bone grafts, declined in the short term. However, as the situation improved and dental practices resumed normal operations, there was a resurgence in demand for bone graft substitutes, driven by increased awareness of oral health and the recovery of elective surgeries.

The allograft bone graft substitutes segment is expected to be the largest during the forecast period

The allograft bone graft substitutes segment is predicted to secure the largest market share throughout the forecast period. Allograft bone graft substitutes are materials derived from human cadaveric bone, typically processed to remove any living cells to reduce the risk of immune rejection. They serve as a scaffold for new bone growth in various orthopedic and dental procedures, such as dental implants and jaw reconstruction. The use of allografts reduces the need for additional surgery and donor site morbidity.

The dental implantology segment is expected to have the highest CAGR during the forecast period

The dental implantology segment is anticipated to witness the highest CAGR during the forecast period. In dental implantology, dental bone graft substitutes play a crucial role in enhancing the success of dental implants by providing structural support for implant placement in areas with insufficient or damaged bone. The use of bone graft substitutes in implantology is essential for improving outcomes in patients with bone loss due to trauma, periodontal disease, or congenital defects, enhancing overall implant success rates.

Region with largest share:

Asia Pacific is expected to register the largest market share during the forecast period driven by increasing dental healthcare awareness, rising disposable incomes, and a growing aging population. Countries like India, China, and Japan are key contributors due to their large patient base and improving access to advanced dental treatments. Additionally, government initiatives and the adoption of innovative biomaterials are expected to fuel market expansion in the region over the coming years.

Region with highest CAGR:

North America is projected to witness the highest CAGR over the forecast period due to a high prevalence of dental issues, alongside an increasing demand for dental implants. The region benefits from advanced healthcare infrastructure, widespread awareness of oral health, and high disposable incomes. The United States, in particular, leads the market with significant demand for innovative bone graft materials like synthetic and allografts. Additionally, the adoption of minimally invasive dental procedures and technological advancements in biomaterials are expected to drive market growth in North America.

Key players in the market

Some of the key players profiled in the Dental Bone Graft Substitutes Market include Medtronic, Geistlich Pharma, Zimmer Biomet, Dentsply Sirona, Straumann Group, BioHorizons, Nobel Biocare, Ace Surgical Supply, RTI Surgical, Dentium, Botiss Biomaterials, Septodont, Osteogenics Biomedical, Biomatlante, Collagen Matrix, Implant Direct Sybron International, Institut Straumann, Maxigen Biotech, Sunstar Americas and Lifenet Health.

Key Developments:

In October 2024, Geistlich Pharma launched the Bio-Oss(R) Pen, an applicator designed to improve the precision of its Bio-Oss(R) bone graft material application. This innovation aims to enhance user control, making it easier to apply the bone graft in minimally invasive surgeries and challenging clinical scenarios.

In October 2024, Nobel Biocare, in partnership with Mimetis Biomaterials, introduced creos(TM) syntogain, a biomimetic synthetic bone graft. Made of 80% calcium-deficient hydroxyapatite (CDHA) and 20% B-tricalcium phosphate, it closely mimics natural bone for enhanced osteoconduction and stability, intended to support efficient regeneration in dental procedures.

Products Covered:

• Synthetic Bone Graft Substitutes
• Allograft Bone Graft Substitutes
• Xenograft Bone Graft Substitutes
• Autograft Bone Graft Substitutes
• Demineralized Bone Matrix (DBM)
• Other Products

Materials Covered:

• Ceramics
• Bioactive Glass
• Polylactic Acid (PLA)
• Polyglycolic Acid (PGA)
• Calcium Sulfate
• Hydroxyapatite (HA)
• Other Materials

Forms Covered:

• Putty
• Granules
• Gels
• Blocks
• Other Forms

Applications Covered:

• Dental Implantology
• Periodontal Defects
• Ridge Augmentation
• Sinus Lift Procedures
• Socket Preservation
• Other Applications

End Users Covered:

• Dental Clinics
• Hospitals
• Research Institutes
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances